FDA investigates child death potentially related to Takeda's enzyme replacement therapy

The FDA said Friday that it is looking into a pediatric patient’s death that appears to be related to Takeda’s Adzynma, which is a treatment for a rare genetic blood disorder. Adzynma is an enzyme ...